- Mar 4, 2014

Improved screening means new targets for pediatric neuroblastoma therapies

Neuroblastoma is one of the most common and lethal types of childhood cancers. In a paper published online today in OncoTarget, a researcher at the University of Texas Health Science Center at San Antonio unveils the important role of microRNAs in regulating neuroblastoma development, pointing to new therapeutic possibilities.

Genes that cause rare hidden cancer revealed

Stopping a rare childhood cancer in its tracks

Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed

New research identifies a potential treatment target for hepatoblastoma in children

Loneliness May Lead to Chronic Conditions Emotional Distress in Young Adult Cancer Survivors

Canadian Pediatric Cancer Consortium launches to advance research in paediatric cancer care

Oncological emergencies: A must know condition for families with childhood cancer

Colin Seaman is the boy with the Harry Potter cells

New drug combination may effectively treat often fatal childhood brain tumor

New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment

Recent Posts

Improved screening means new targets for pediatric neuroblastoma therapies

Archive

Search By Tags